T
TAU-PNU MEDICAL
Developing minimally invasive treatments for heart conditions
About TAU-PNU MEDICAL
Tau Medical specializes in developing state-of-the-art cardiac implant systems designed to treat tricuspid regurgitation (TR) through minimally invasive procedures. Their flagship product, the Pivot Bridge, is a novel cardiac implant system that provides a temporary solution for TR, intended for use in the days leading up to scheduled tricuspid valve repair or replacement surgeries. The company operates in the medical device sector, focusing primarily on cardiovascular health. Tau Medical serves healthcare providers and medical institutions that require advanced, investigational cardiac treatments. Their business model revolves around research and development, with a strong emphasis on intellectual property protection and innovation. Revenue is generated through partnerships, grants, and future commercialization of their investigational devices.
Source: Dealroom company dataNews
Open roles
TAU-PNU MEDICAL in the Yangsan-si ecosystem
The TAU-PNU MEDICAL office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Stonebridge
STIC Ventures
SmileGate Investment
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about TAU-PNU MEDICAL on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See TAU-PNU MEDICAL on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

